Insilicogen and German QuiaGen to Establish and Operate 'Domestic Bio Data Center'
Bioinformatics specialist company Insilicogen Inc. announced on the 11th that it will jointly install and operate a domestic data center with global biotechnology company QIAGEN. QIAGEN is a German bio company that supplies DNA and RNA extraction kits and gene analysis software worldwide.
According to Insilicogen, QIAGEN's domestic data center installation will be the third in the world, following Denmark and the United States. The 'QCII' data center installed in Korea is a web-based software that curates large-scale bioinformatics databases to facilitate access to the field of precision medicine.
QCII is the first NGS interpretation platform to obtain approval under the European In Vitro Diagnostic Medical Device Regulation (CE-IVDR). It supports personalized treatment by clinically interpreting gene variants analyzed from NGS (Next-Generation Sequencing) data.
Hot Picks Today
"Wow, Have Middle-Aged Men Had This All to Themselves?"... Women in Their 20s and 30s Find Comfort in a Standing Drink
- "Koreans Spend 1 Million Won Each and Come Back"... 'They Said They Were Going for Value for Money,' but Open Their Wallets Wide in Japan
- They Earn “430 Million Won a Year” Yet Receive Government Aid... AI Hub Declares Emergency Over “8.8 Million Won Monthly Rent”
- "Naked Again?" Controversial Actress Crosses a Line... Slammed for Sexualizing 'Child Characters'
- "They Get a Good Night's Sleep and Earn Twice My Salary... Honestly, I'm So Jealous I Could Die": Civil Servant's Post Targeting Firefighters Sparks Outrage
An Insilicogen official explained, "QIAGEN has established the QCII data center domestically to enable clinical interpretation of NGS variant data in Korea while complying with domestic medical and data-related laws."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
